NEW YORK (GenomeWeb) – Meridian Bioscience today reported a 6 percent increase in fiscal fourth quarter revenues and a 2 percent increase in fiscal year 2017 revenues.

For the quarter ended Sept. 30, the diagnostics manufacturer reported revenue of $49.7 million compared to $47.0 million in the prior year, above analysts' consensus estimate of $48.1 million and slightly above preliminary earnings announced last month of $49.5 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.